Skip to content
OpenCapital
Get started

BioLife Solutions BLFS Gross unrealized Gains, current portion

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02—

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%—
Operating margin-16.7%—
Net margin-68.7%—
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0×0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept blfs:DebtSecuritiesAvailableforsaleUnrealizedGainCurrent.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's gross unrealized gains, current portion.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's gross unrealized gains, current portion?
BioLife Solutions (BLFS) reported gross unrealized gains, current portion of $28K in Q1 2026.
How has BioLife Solutions's gross unrealized gains, current portion changed year-over-year?
BioLife Solutions's gross unrealized gains, current portion increased by 55.6% year-over-year, from $18K to $28K.
What is the long-term trend for BioLife Solutions's gross unrealized gains, current portion?
Over 3 years (2022 to 2025), BioLife Solutions's gross unrealized gains, current portion has grown at a 137.7% compound annual growth rate (CAGR), from $7K to $94K.